Inozyme Pharma, Inc.·4

Jan 14, 4:17 PM ET

Huertas Pedro 4

4 · Inozyme Pharma, Inc. · Filed Jan 14, 2021

Insider Transaction Report

Form 4
Period: 2021-01-13
Huertas Pedro
See Remarks
Transactions
  • Award

    Stock Option (Right to buy)

    2021-01-13+36,07436,074 total
    Exercise: $2.77Exp: 2030-04-22Common Stock (36,074 underlying)
Footnotes (1)
  • [F1]This option was granted on April 23, 2020, with vesting subject to the satisfaction of performance based vesting criteria. The performance based vesting criteria were satisfied on January 13, 2021 and the shares underlying the option vest in equal monthly installments from April 23, 2020 through April 23, 2024.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION